Here's why Westpac Banking Corp was slammed today

Westpac Banking Corp (ASX:WBC) was amongst the market's worst performing stocks on Tuesday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Westpac Banking Corp (ASX: WBC) was amongst the market's worst performing stocks today and acted as a key drag on the Australian sharemarket as a whole.

The stock fell 2% compared to the S&P/ASX 200's (Index: ^AXJO) (ASX: XJO) 1.5% decline. Westpac's fall saw more than $2 billion wiped from its market value. Commonwealth Bank of Australia (ASX: CBA), Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd. (ASX: NAB) delivered similar performances, declining 1.3%, 0.9% and 1.7% respectively.

Each of the banks have come under considerable selling pressure in recent months as the market has finally come to recognise the headwinds facing the sector. In May, Westpac delivered a disappointing half-year earnings report while it was also forced to issue $2 billion of new shares to increase its capital buffer, ultimately diluting shareholder ownership.

Prior to that it also admitted that dividend payout ratios across the sector had likely peaked, citing the need to have "sufficient capital to back your activity as you look forward."

The bank extended its declines today as a result of the Reserve Bank of Australia's latest decision on interest rates. At 2:30pm (Sydney time), the central bank announced that the nation's official cash rate would remain unchanged for at least one more month which saw the market's appetite for expensive high-yield dividend stocks decline even further.

Although the bank's shares have lost more than 19% since peaking in April, the stock is by no means in bargain territory. While there is certainly scope for a recovery in the near-term, it stands little chance of delivering market-beating returns in the long-run, making it a stock for 'Foolish' investors to avoid.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »